1144 related articles for article (PubMed ID: 21984749)
1. Association between deletion size and important phenotypes expands the genomic region of interest in Phelan-McDermid syndrome (22q13 deletion syndrome).
Sarasua SM; Dwivedi A; Boccuto L; Rollins JD; Chen CF; Rogers RC; Phelan K; DuPont BR; Collins JS
J Med Genet; 2011 Nov; 48(11):761-6. PubMed ID: 21984749
[TBL] [Abstract][Full Text] [Related]
2. 22q13.2q13.32 genomic regions associated with severity of speech delay, developmental delay, and physical features in Phelan-McDermid syndrome.
Sarasua SM; Dwivedi A; Boccuto L; Chen CF; Sharp JL; Rollins JD; Collins JS; Rogers RC; Phelan K; DuPont BR
Genet Med; 2014 Apr; 16(4):318-28. PubMed ID: 24136618
[TBL] [Abstract][Full Text] [Related]
3. Molecular characterisation of patients with subtelomeric 22q abnormalities using chromosome specific array-based comparative genomic hybridisation.
Koolen DA; Reardon W; Rosser EM; Lacombe D; Hurst JA; Law CJ; Bongers EM; van Ravenswaaij-Arts CM; Leisink MA; van Kessel AG; Veltman JA; de Vries BB
Eur J Hum Genet; 2005 Sep; 13(9):1019-24. PubMed ID: 15986041
[TBL] [Abstract][Full Text] [Related]
4. [The Phelan-McDermid syndrome (22q13 microdeletion) - case report].
Slezak R; Laczmańska I
Med Wieku Rozwoj; 2011; 15(1):96-100. PubMed ID: 21786519
[TBL] [Abstract][Full Text] [Related]
5. Clinical and genomic evaluation of a Chinese patient with a novel deletion associated with Phelan-McDermid syndrome.
Lei D; Li S; Banerjee S; Zhang H; Li C; Hou S; Chen D; Yan H; Li H; Peng HH; Liu S; Zhang X; Peng Z; Wang J; Yang H; Huang H; Wu J
Oncotarget; 2016 Dec; 7(49):80327-80335. PubMed ID: 27741506
[TBL] [Abstract][Full Text] [Related]
6. Chromosome 22q13.3 deletion syndrome with a de novo interstitial 22q13.3 cryptic deletion disrupting SHANK3.
Delahaye A; Toutain A; Aboura A; Dupont C; Tabet AC; Benzacken B; Elion J; Verloes A; Pipiras E; Drunat S
Eur J Med Genet; 2009; 52(5):328-32. PubMed ID: 19454329
[TBL] [Abstract][Full Text] [Related]
7. [Muscular hypotonia, developmental retardation, speech delay and mildly dysmorphic features: 22q13 deletion syndrome (Phelan-McDermid Syndrome) as an important differential diagnosis].
Strenge S; Froster UG; Kujat A; Bernhard M; Merkenschlager A
Klin Padiatr; 2008; 220(5):318-20. PubMed ID: 18814345
[TBL] [Abstract][Full Text] [Related]
8. A Brazilian cohort of individuals with Phelan-McDermid syndrome: genotype-phenotype correlation and identification of an atypical case.
Samogy-Costa CI; Varella-Branco E; Monfardini F; Ferraz H; Fock RA; Barbosa RHA; Pessoa ALS; Perez ABA; Lourenço N; Vibranovski M; Krepischi A; Rosenberg C; Passos-Bueno MR
J Neurodev Disord; 2019 Jul; 11(1):13. PubMed ID: 31319798
[TBL] [Abstract][Full Text] [Related]
9. Intranasal insulin to improve developmental delay in children with 22q13 deletion syndrome: an exploratory clinical trial.
Schmidt H; Kern W; Giese R; Hallschmid M; Enders A
J Med Genet; 2009 Apr; 46(4):217-22. PubMed ID: 18948358
[TBL] [Abstract][Full Text] [Related]
10. Interstitial 22q13 deletions not involving SHANK3 gene: a new contiguous gene syndrome.
Disciglio V; Lo Rizzo C; Mencarelli MA; Mucciolo M; Marozza A; Di Marco C; Massarelli A; Canocchi V; Baldassarri M; Ndoni E; Frullanti E; Amabile S; Anderlid BM; Metcalfe K; Le Caignec C; David A; Fryer A; Boute O; Joris A; Greco D; Pecile V; Battini R; Novelli A; Fichera M; Romano C; Mari F; Renieri A
Am J Med Genet A; 2014 Jul; 164A(7):1666-76. PubMed ID: 24700646
[TBL] [Abstract][Full Text] [Related]
11. Cerebellar and posterior fossa malformations in patients with autism-associated chromosome 22q13 terminal deletion.
Aldinger KA; Kogan J; Kimonis V; Fernandez B; Horn D; Klopocki E; Chung B; Toutain A; Weksberg R; Millen KJ; Barkovich AJ; Dobyns WB
Am J Med Genet A; 2013 Jan; 161A(1):131-6. PubMed ID: 23225497
[TBL] [Abstract][Full Text] [Related]
12. The deletion 22q13 syndrome: a new case.
Karaman A; Aydin H; Geçkinli B; Göksu K
Genet Couns; 2015; 26(1):53-60. PubMed ID: 26043508
[TBL] [Abstract][Full Text] [Related]
13. 22q13.3 deletion syndrome: a recognizable malformation syndrome associated with marked speech and language delay.
Cusmano-Ozog K; Manning MA; Hoyme HE
Am J Med Genet C Semin Med Genet; 2007 Nov; 145C(4):393-8. PubMed ID: 17926345
[TBL] [Abstract][Full Text] [Related]
14. 22q13.3 deletion syndrome: clinical and molecular analysis using array CGH.
Dhar SU; del Gaudio D; German JR; Peters SU; Ou Z; Bader PI; Berg JS; Blazo M; Brown CW; Graham BH; Grebe TA; Lalani S; Irons M; Sparagana S; Williams M; Phillips JA; Beaudet AL; Stankiewicz P; Patel A; Cheung SW; Sahoo T
Am J Med Genet A; 2010 Mar; 152A(3):573-81. PubMed ID: 20186804
[TBL] [Abstract][Full Text] [Related]
15. Deletion 22q13.3 syndrome.
Phelan MC
Orphanet J Rare Dis; 2008 May; 3():14. PubMed ID: 18505557
[TBL] [Abstract][Full Text] [Related]
16. A patient with the classic features of Phelan-McDermid syndrome and a high immunoglobulin E level caused by a cryptic interstitial 0.72-Mb deletion in the 22q13.2 region.
Simenson K; Õiglane-Shlik E; Teek R; Kuuse K; Õunap K
Am J Med Genet A; 2014 Mar; 164A(3):806-9. PubMed ID: 24375995
[TBL] [Abstract][Full Text] [Related]
17. Microdeletion at chromosome 4q21 defines a new emerging syndrome with marked growth restriction, mental retardation and absent or severely delayed speech.
Bonnet C; Andrieux J; Béri-Dexheimer M; Leheup B; Boute O; Manouvrier S; Delobel B; Copin H; Receveur A; Mathieu M; Thiriez G; Le Caignec C; David A; de Blois MC; Malan V; Philippe A; Cormier-Daire V; Colleaux L; Flori E; Dollfus H; Pelletier V; Thauvin-Robinet C; Masurel-Paulet A; Faivre L; Tardieu M; Bahi-Buisson N; Callier P; Mugneret F; Edery P; Jonveaux P; Sanlaville D
J Med Genet; 2010 Jun; 47(6):377-84. PubMed ID: 20522426
[TBL] [Abstract][Full Text] [Related]
18. Clinical and genomic evaluation of 201 patients with Phelan-McDermid syndrome.
Sarasua SM; Boccuto L; Sharp JL; Dwivedi A; Chen CF; Rollins JD; Rogers RC; Phelan K; DuPont BR
Hum Genet; 2014 Jul; 133(7):847-59. PubMed ID: 24481935
[TBL] [Abstract][Full Text] [Related]
19. A de novo 7.9 Mb deletion in 22q13.2→qter in a boy with autistic features, epilepsy, developmental delay, atopic dermatitis and abnormal immunological findings.
Chen CP; Lin SP; Chern SR; Tsai FJ; Wu PC; Lee CC; Chen YT; Chen WL; Wang W
Eur J Med Genet; 2010; 53(5):329-32. PubMed ID: 20541044
[TBL] [Abstract][Full Text] [Related]
20. Further delineation of deletion 1p36 syndrome in 60 patients: a recognizable phenotype and common cause of developmental delay and mental retardation.
Battaglia A; Hoyme HE; Dallapiccola B; Zackai E; Hudgins L; McDonald-McGinn D; Bahi-Buisson N; Romano C; Williams CA; Brailey LL; Zuberi SM; Carey JC
Pediatrics; 2008 Feb; 121(2):404-10. PubMed ID: 18245432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
